Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2002-12-12
pubmed:abstractText
The rationale for using tazarotene in oral lichen planus (OLP) is its regulatory action on the growth and differentiation of keratinocytes and on inflammation. This randomized, placebo-controlled study addresses evaluation of the effects of topic tazarotene in the treatment of OLP.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
D
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1354-523X
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
291-5
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12477060-Administration, Topical, pubmed-meshheading:12477060-Aged, pubmed-meshheading:12477060-Cell Differentiation, pubmed-meshheading:12477060-Cell Division, pubmed-meshheading:12477060-Female, pubmed-meshheading:12477060-Gels, pubmed-meshheading:12477060-Humans, pubmed-meshheading:12477060-Keratinocytes, pubmed-meshheading:12477060-Keratolytic Agents, pubmed-meshheading:12477060-Lichen Planus, Oral, pubmed-meshheading:12477060-Male, pubmed-meshheading:12477060-Matched-Pair Analysis, pubmed-meshheading:12477060-Middle Aged, pubmed-meshheading:12477060-Nicotinic Acids, pubmed-meshheading:12477060-Placebos, pubmed-meshheading:12477060-Remission Induction, pubmed-meshheading:12477060-Retinoids, pubmed-meshheading:12477060-Sensation Disorders, pubmed-meshheading:12477060-Single-Blind Method, pubmed-meshheading:12477060-Statistics, Nonparametric, pubmed-meshheading:12477060-Taste Disorders, pubmed-meshheading:12477060-Treatment Outcome
pubmed:year
2002
pubmed:articleTitle
Oral lichen planus: a preliminary clinical study on treatment with tazarotene.
pubmed:affiliation
Department of Odontostomatology and Surgery, University of Bari, Bari, Italy. petruzmf@tin.it
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial